Skip to content
← Back to this collection

PUBLICATIONS · 33021870

Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Dec 1
First author
Dimopoulos MA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Mar 10;40(8):919. doi: 10.1200/JCO.22.00210.
    note
    Source null
    related pmid
    35255230
    relationship
    Erratum in

Authors and identifiers

  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Špička I
    type
    Author
  3. name
    Quach H
    type
    Author
  4. name
    Oriol A
    type
    Author
  5. name
    Hájek R
    type
    Author
  6. name
    Garg M
    type
    Author
  7. name
    Beksac M
    type
    Author
  8. name
    Bringhen S
    type
    Author
  9. name
    Katodritou E
    type
    Author
  10. name
    Chng WJ
    type
    Author
  11. name
    Leleu X
    type
    Author
  12. name
    Iida S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dimopoulos MA
    type
    Author
  2. name
    Špička I
    type
    Author
  3. name
    Quach H
    type
    Author
  4. name
    Oriol A
    type
    Author
  5. name
    Hájek R
    type
    Author
  6. name
    Garg M
    type
    Author
  7. name
    Beksac M
    type
    Author
  8. name
    Bringhen S
    type
    Author
  9. name
    Katodritou E
    type
    Author
  10. name
    Chng WJ
    type
    Author
  11. name
    Leleu X
    type
    Author
  12. name
    Iida S
    type
    Author
bibliography ids
  1. nci-bib-5eb9abee373221026ddf6518
book metadata
content sha256
c07d912c660963540c39ca00cbb185371a84448af465231d7b1f2c1ed8cc0772
document type
citation
dois
  1. 10.1200/JCO.20.02060
electronic publication date
display
2020 Oct 6
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33021870
immutable id
pubmed:33021870@c07d912c660963540c39ca00cbb185371a84448af465231d7b1f2c1ed8cc0772
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
34
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4030-4041
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 Mar 10;40(8):919. doi: 10.1200/JCO.22.00210.
    note
    Source null
    related pmid
    35255230
    relationship
    Erratum in
outcomes validated
false
pmid
33021870
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
78efa9065a0aa16aa8fc870c0d522f38bdadb4cf7b873f3915cbb166e47fa4b0
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Dec 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33021870/
title
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial.

Preserved source evidence · Not medical advice